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Abstract The tumor microenvironment is acidic as a
consequence of upregulated glycolysis and poor perfusion
and this acidity, in turn, promotes invasion and metastasis.
We have recently demonstrated that chronic consumption
of sodium bicarbonate increased tumor pH and reduced
spontaneous and experimental metastases. This occurred
without affecting systemic pH, which was compensated.
Additionally, these prior data did not rule out the possi-
bility that bicarbonate was working though effects on
carbonic anhydrase, and not as a buffer per se. Here, we
present evidence that chronic ingestion of a non-volatile
buffer, 2-imidazole-1-yl-3-ethoxycarbonylpropionic acid
(IEPA) with a pKa of 6.9 also reduced metastasis in an
experimental PC3M prostate cancer mouse model. Animals
(n = 30) were injected with luciferase expressing PC3M
prostate cancer cells either subcutaneously (s.c., n = 10) or
intravenously (i.v., n = 20). Four days prior to inocula-
tions, half of the animals for each experiment were pro-
vided drinking water containing 200 mM IEPA buffer.
Animals were imaged weekly to follow metastasis, and
these data showed that animals treated with IEPA had
signiﬁcantly fewer experimental lung metastasis compared
to control groups (P\0.04). Consistent with prior work,
the pH of treated tumors was elevated compared to con-
trols. IEPA is observable by in vivo magnetic resonance
spectroscopy and this was used to measure the presence of
IEPA in the bladder, conﬁrming that it was orally available.
The results of this study indicate that metastasis can be
reduced by non-volatile buffers as well as bicarbonate and
thus the effect appears to be due to pH buffering per se.
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ethoxycarbonylpropionic acid
MEM/EBSS Minimum essential media/Earle’s balanced
salts
MMP Matrix metalloproteinase
MR/I/S Magnetic resonance imaging/spectroscopy
OD Outer diameter
PBS Phosphate buffered saline
STEAM Stimulated echo acquisition mode; a varian
pulse sequence for localized magnetic
resonance spectroscopy
TE/TR/TM Echo time/repetition time/mixing time
MR Pulse sequence parameters
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Acidosis is a common microenvironmental feature of most
solid tumors [1]. Acidiﬁcation of the extra cellular space is
a consequence of high rates of glucose metabolism com-
bined with inefﬁcient tumor perfusion [2, 3]. Low extra-
cellular pH can induce tumor cell migration, invasion and
metastasis by poorly deﬁned mechanisms [4, 5]. Acute
exposure of cells to acidic pH has been shown to cause up-
regulation of several secreted proteases, such as cathepsins
D, L, and/or B, [6–8] and increase expression of the matrix
metalloproteinases (MMP); MMP-2 (gelatinase A) and
MMP-9 (gelatinase B) in vitro [9, 10]. Additionally, pre-
treatment of melanoma cells with acidic pH before tail vein
injection leads to increased experimental metastases in
vivo [11, 12]. We have shown previously that neutralizing
the acid pH of tumors with oral NaHCO3 reduced sponta-
neous metastases without affecting systemic pH [13].
Mathematical reaction-diffusion type models were used to
quantitatively describe the effect, thus providing a theo-
retical framework within which to interpret the data. The
pKa of NaHCO3 in water is 6.14 [14]; and models predicted
that the most efﬁcacious buffers would have a pKa of
*7.0. Additionally, the models assumed that bicarbonate
was working as a buffer per se, and did not assume a
speciﬁc interaction with carbonic anhydrases, which are
used in vivo to dehydrate HCO3
-. The current study was
undertaken to test the efﬁcacy of a non-bicarbonate/non-
volatile buffer with a higher pKa on tumor growth and
metastases. For this, we have used a non-volatile buffer
with a pKa of *6.9, 2-imidazole-1-yl-3-ethoxycarbonyl-
propionic acid (IEPA).
IEPA is a synthetic imidazole buffer that has been used
to map the extracellular pH, pHe, in different animal
models using magnetic resonance spectroscopic imaging,
MRSI [15–17]. In this paper, we studied the effect of IEPA
on spontaneous and experimental metastases. We ﬁrst
showed that oral IEPA was tolerable at doses up to
200 mM, as evidenced by animal weight gain. We dem-
onstrated that IEPA was absorbed into the systemic cir-
culation using MRS. Measurement of the pH in the primary
subcutaneous tumor showed that IEPA slightly increased
the tumor pH. IEPA also had a moderate but statistically
insigniﬁcant effect on the growth rate of the primary tumor,
which was consistent with previous results using bicar-
bonate. We then observed that IEPA had a signiﬁcant
inhibitory effect on experimental metastases in the PC3M
prostate model. Although the mechanism by which inhib-
iting metastases has not yet been determined, these data
combined with the previous bicarbonate studies [14]
demonstrate that non-volatile buffers are effective in
reducing tumor metastases, and thus the effects appear to
be due to buffering per se.
Materials and methods
Chemicals
IEPA (2-imidazole-1-yl-3-ethoxycarbonyl-propionic acid)
was obtained from Dr. Paloma Ballesteros (Laboratory of
Organic Synthesis and Molecular Imaging by Magnetic
Resonance (Ref. Lab. 250) Faculty of Sciences, UNED P8
Senda del Rey, 9 28040-Madrid, Spain), and was dissolved
in tap water at a concentration of 200 mM. The pH of the
IEPA solution was adjusted to 7.4 (using 1 M HCl) and
then given to the mice to drink in place of their regular tap
water. Cell culture media and supplies were obtained from
Invitrogen, Carlsbad, CA. Luciferin was obtained from
Gold Biotechnology, St. Louis, MO.
Animals housing and diet
All animals were maintained in accordance with IACUC
standards of care in pathogen free rooms, in the Mofﬁtt
Cancer Research Center (Tampa, FL) Vivarium. All
imaging and measurements were performed within the
facility. Three days prior to inoculation with tumor cells,
4–6 week old male beige SCID mice (Harlan, Madison,
WI) were placed in two cohorts per experiment, which
were allowed to drink either tap water or 200 mM IEPA.
The weights of the water bottles were recorded before and
after providing them to the animals, thereby tracking the
amount of liquid consumed per cage. Animal weights were
measured and recorded twice weekly, and the overall
health of each animal was noted to ensure timely endpoints
within the experiment.
Cell culture and inoculation
PC3M cells (-Luc6 clone) were obtained from Caliper
(Hopkinton, MA). The cells were cultured using MEM/
EBSS media, supplemented with 10% fetal bovine serum,
1% penicillin streptomycin, 1% nonessential amino acids,
1% sodium pyruvate and 1% MEM vitamins. In prepara-
tion for inoculation into mice, the cells were trypsinized
and rinsed once with sterile phosphate buffered saline
(PBS) prior to resuspension at a concentration of 5 9 10
6
cells in 200 ll PBS. For primary tumor injection, animals
were prepared by removing the hair from the injection site,
and 200 ll containing 5 9 10
6 cells in PBS were injected
subcutaneously into the right ﬂank of each mouse. For
experimental metastases, 200 ll containing 5 9 10
6 cells
in PBS were injected directly and slowly (over the course
of 1 min) into the tail vein of each mouse. In both prepa-
rations, cell distributions were veriﬁed by bioluminescent
imaging immediately following injection.
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Animals were anesthetized with isoﬂurane and injected
intraperitoneally with 10 ll per g body weight of sterile
d-luciferin substrate prepared in PBS at 15 mg/ml (result-
ing dose 150 lg/g body weight). After 5 min, mice were
transferred to the thermo-regulated, light-tight chamber of
the In Vivo Imaging System, IVIS-200 (Caliper; Hopkin-
ton, MA). Photographic images were acquired ﬁrst, and the
bioluminescent images were overlaid on top of these
images. Bioluminescent images were acquired by mea-
suring photons emitted from luciferase-expressing cells and
transmitted through the tissue. The exposure time for the
bioluminescent image acquisition ranged from 0.5 s (whole
tumor images) up to 2 min (lung metastases) to ensure non-
saturation, and differences in exposure time were corrected
by expressing data as total ﬂux in photons/sec, rather than
photon counts. Images were analyzed using the Living-
Image software (Caliper; Hopkinton, MA).
Necrosis counting
The center section (*5 mm) of the subcutaneous tumor of
each animal was ﬁxed in parafﬁn blocks prior to staining
one 4 lm thick cross-sectional sample per animal with
hematoxylin and eosin for histology. Histology slides were
scanned using the Aperio
TM
(Vista, CA) ScanScope XT
with a 209/0.8NA objective lens (2009) at a rate of 2 min
per slide via Basler tri-linear-array. Image analysis was
performed using an Aperio Genie
 v1 customized
algorithm in conjunction with Positive Pixel Count v9 with
the following optimized thresholds [Hue value = 0.2;
Hue width = 0.6; color saturation threshold = 0.05;
IWP(High) = 210; Iwp(Low) = Ip(High) = 160; Ip(low)
= Isp(High) = 80; Isp(Low) = 0]. The algorithm was
applied to the entire slide’s digital image to determine the
percentage of necrosis by detecting the number of pixels
that satisfy the color and intensity speciﬁcation deﬁned
above (necrotic), divided by the number of pixels in non-
necrotic tissue. The training algorithm developed above
was quality controlled by a practicing pathologist.
Magnetic resonance imaging and spectroscopy
MR images and spectra were obtained on a Varian MR
imaging spectrometer ASR310 (Agilent Life Sciences
Technologies, Santa Clara, CA) with a 30 cm horizontal
clearboreoperatingataﬁeldstrengthof7 T.Forreference,a
high resolution spectrum of IEPA in D2O was obtained on a
Varian Nuclear Magnetic Resonance spectrometer with a
54 mm vertical bore opening at a ﬁeld strength of 9.4 T. For
in vivo spectroscopic imaging, naı ¨ve mice were allowed to
drink IEPA for 3 days prior to imaging. The animals were
sedated using isoﬂurane, placed in the animal cradle for
insertionintotheboreofthe7 TVarianMRIandmaintained
warm using a continuous warm air blower (Small Animal
Instruments, Inc., Stonybrook, NY). Temperatures were
measured using a ﬁber optic endorectal thermometer in
conjunction with the MR compatible animal monitoring
system (Model 1025, Small Animal Instruments, Inc. Stony
Brook, NY.). SCOUT images were taken to verify location,
and T2 weighted images for anatomical identiﬁcation were
obtained using an fast spin echo (FSEMS) pulse sequence,
with FOV = 40 9 80 (mm), 15 coronal slices, 1 mm thick,
no gap, TR = 2450 s, effective TE = 72 ms, with fat sup-
pression on. Spectra were obtained using a stimulated echo
(STEAM) localization sequence on a 2 9 2 9 2.5 mm
3
voxelinthebladderwith256averages(ﬂipangle90 deg,TE
9.44, TM 8.01, and TR 2000), for an 8.5 min acquisition.
Images and spectra were processed using the Varian Vnmrj
softwareorusingMATLAB(MathWorks,Inc,Natick,MA).
Electrode measurement of pH
Animals were sedated using isoﬂurane, and placed on a
warming surface to maintain appropriate body temperature
for the duration of the experiment. Both the needle
microelectrode and the reference electrode were obtained
from Microelectrodes, Inc., (Bedford, NH). A shallow
small (\5 mm) incision was made in an alternate (non
tumor) site and the 1 mm reference electrode was placed
subcutaneously therein. A needle micro electrode (OD
0.8 mm with a beveled end) was inserted up to 1.3 cm into
the center of the tumor, and was held in place for up to
1 min, until pH readings stabilized. The needle was rotated
once in each location, to allow the pH electrode to re-read
at the same depth in order to make two independent mea-
surements per location. The pH was measured at three
locations, one near the center/core of the tumor, one in a
mid region of the tumor, and one at the rim of the tumor;
these values were averaged to report a mean for each
animal. After the pH was measured in the primary tumor,
the animals were euthanized (29 days after subcutaneous
injection of the primary tumor cells). Before and after the
pH was measured in each animal, the pH electrodes were
used to measure a standard pH 7 buffer solution (Thermo
Fisher Scientiﬁc, Inc., Waltham, MA).
Statistics
Non-paired data were analyzed for differences in their
mean by two-tailed Student’s t-test. Chauvenet’s criterion
was used for outlier analysis of independent data sets. A
mouse was rejected from its set based on an expected
deviance value of below one-half. The expected deviance
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one-half showing two otherwise valid sets [18].
Results
IEPA is tolerable and orally available
IEPA (Fig. 1a) is a synthetic imadizolic base with a pKa of
6.9. When added to drinking water at a concentration of
200 mM, mice appear to thrive. The water consumption
was not signiﬁcantly different in the IEPA group compared
to that of animals consuming tap water (Fig. 1b). No
behavioral alterations were noted and there was no effect
on animal weight maintenance or gain (Fig. 1c).
IEPA can be detected in vivo via magnetic resonance
spectroscopy, which has been used as a pH sensitive agent
using magnetic resonance spectroscopic imaging, MRSI
[17]. Although IEPA is an MRS imaging agent, a pH
electrode was chosen for this experiment in order to avert
potential confounding effects of this buffer on the mea-
surement itself. To image pH with IEPA, it must be given
Fig. 1 a Name and chemical
structure of IEPA. b Average
water consumption over time in
the two cohorts (Tap and IEPA;
n = 10 each) indicating no
difference in the amount of
water consumption between the
treatments. c Average mouse
weight over time between
cohorts of mice drinking either
tap water (Tap) or tap water
buffered with 200 mM IEPA
(IEPA), showing no signiﬁcant
difference in weight gain or loss
between the two treatment
groups (n = 10 each for tap and
IEPA). d T2 weighted coronal
image of one mouse which had
been drinking IEPA for 2 days.
The green square indicates the
voxel in the bladder from which
the spectrum of IEPA was
obtained. e A reference
spectrum of 200 mM IEPA
obtained at 9.4 T. f Spectrum of
IEPA obtained from the bladder
(d) showing the same peaks as
the reference spectrum, and
indicating that the buffered
IEPA was absorbed into the
blood stream and ﬁltered
through the kidneys (rather than
being directly excreted through
the intestines)
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establish high enough concentrations of IEPA at the site of
pH measurement. Given as a 0.15 ml intraperitoneal bolus
injection at 310 mM (as in [17]) this should result in a
concentration detectable by MRSI but low enough to have
no effect on the pH. However higher steady-state concen-
trations of IEPA can carry the risk that IEPA itself may
alter the pH that is sought to be measured [19]. Addition-
ally, to measure the pH, IEPA would also have to be
infused in the non-treated animals. In order to ensure a
distinct separation between treated and untreated animals,
IEPA was used only as a buffer and not as an MRSI agent
for the purposes of this study.
However, to assess whether ingested IEPA was absor-
bed into the systemic circulation, MR spectra were
obtained from voxels within the bladder of animals that had
been drinking IEPA for 2 days. These data showed that
there was sufﬁcient IEPA in the bladder (Fig. 1d) to obtain
spectra (reference spectrum Fig. 1e, spectrum in bladder
Fig. 1f), indicating that it was ﬁltered through the kidneys,
and thus was absorbed into the blood stream and system-
ically available.
Effect of IEPA on PC3M primary tumor growth, pH
and spontaneous metastases
To investigate the effect of IEPA on primary tumor growth,
we injected Luciferase expressing prostate cancer cells,
PC3M-luc, subcutaneously into the right ﬂank of male
SCID mice. Four days prior to injections, half of the animals
were provided with 200 mM IEPA in their drinking water.
Animals were imaged weekly via bioluminescence. Images
from representative animals (Fig. 2a) illustrate growth of
the primary tumor in both cohorts of animals. However, the
plot of bioluminescence of the primary tumor versus time
(Fig. 2b) suggested a trend towards slower tumor growth in
the IEPA treated animals. An unpaired two-tailed Students
t-test, however, showed that these differences did not reach
statistical signiﬁcance (P B 0.06).
The tumor pH was taken immediately prior to eutha-
nasia (29 days after injection of the primary tumor), and
the tumors were harvested immediately afterwards. The
mean tumor pH for each animal was averaged within each
treatment group (tap versus IEPA); and the error was cal-
culated as the standard error between the mean tumor pH in
each group. Tumor pH measurements showed that,
although the effects of IEPA were modest, the pH values of
treated tumors were slightly higher (P B 0.01) than that of
untreated tumors (Fig. 3a). Acidosis can induce both
necrosis and apoptosis [20, 21]. Hence, in this system, we
investigated whether IEPA treated tumors exhibited altered
levels of cell death. Necrosis of the primary tumor were
studied by H&E staining and counted by area, as outlined
in Methods. The results of this analysis are shown in
Table 1. Sample histological images are shown in Fig. 3b
(Tap) and c (IEPA). These data indicate that the IEPA-
treated tumors exhibited signiﬁcantly less necrosis than
controls (Fig. 3d; P B 0.05).
Metastasis is a process that includes a series of distinct
steps starting with penetration of cancer cells through the
basement membrane; local invasion into the surrounding
tissue; intravasation to lymphatic or blood then extravasa-
tion and colonization in a new host organ [22]. To study the
effect of IEPA on the entire metastasis paradigm, biolu-
minescent images were obtained from the thoracic regions
of each cohort (IEPA vs. tap) of animals beginning
3 weeks after subcutaneous injection to form the primary
tumor. These images were obtained in addition to the
whole-body bioluminescence imaging which was used to
monitor primary tumor growth. Because the primary
tumors were much larger than the metastases, and therefore
Fig. 2 a Representative bioluminescence images of one mouse from
each cohort (Tap vs. IEPA) at days 0, 7, 21 and 28 post subcutaneous
injection of luciferase expressing PC3M prostate cancer cells. b Mean
tumor bioluminescence of each cohort (n = 5 each) plotted versus
time post injection showing an increase in bioluminescence with time
for both groups
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opaque material during the lung imaging sessions. The
thoracic region was imaged because the lungs are known to
be one of the primary sites of metastases for this tumor
model. Through these in vivo measurements, the thoracic
region in the IEPA cohort was observed to have
signiﬁcantly fewer metastases compared to controls at
28 days (Fig. 4; P B 0.02). Thus, although IEPA did not
have a signiﬁcant effect on primary tumor growth, it did
reduce the numbers of spontaneous metastases in this
system.
IEPA reduces experimental metastasis
The above data indicate that IEPA reduces spontaneous
metastases, which involves both intravasation and extrav-
asation, with only a moderate, non-signiﬁcant effect on the
primary tumor. This is consistent with previous studies
using bicarbonate [13]. Because the effects of these buffers
were limited mainly to the metastases, we then investigated
whether IEPA affected the efﬁciency of extravasation and
colonization with an experimental metastases model,
wherein PC3M cells were injected directly into the tail vein
of mice consuming either 200 mM IEPA or tap water. The
results (Fig. 5) showed that IEPA led to a signiﬁcant
decrease in the appearance of lung metastases for up to
6 weeks after injection. These ﬁndings indicate that IEPA
signiﬁcantly inhibited extravasation and or colonization in
this experimental metastases model with PC3M cells. After
6 weeks there were approximately 1 9 10
8 photons/sec
from the control mice and only ca. 3 9 10
6 photons/sec
emanating from the thoracic area of mice treated with
IEPA (P B 0.002).
Discussion
Previous work has shown that a volatile buffer, i.e. bicar-
bonate, was effective in inhibiting spontaneous and
experimental metastases [13]. The aim of the current study
Fig. 3 a The average pH of the tumors (prior to excision) for each
cohort, showing a higher pH in the IEPA animals (Error bars
represent SEM within each group; n = 5 for both IEPA and tap).
H&E results from representative tumors from b mouse 4—TAP and
c mouse 7—IEPA. d The average percent necrosis for each cohort,
showing a larger necrotic portion in the TAP animals
Table 1 The results of analysis after immunohistological staining
with hematoxylin and eosin
Sample ID Treatment Necrotic
tissue
area
Total area Percent
necrotic
tissue (%)
Tumor 1 TAP 2276923 113437268 2.01
Tumor 2 TAP 11281434 91144941 12.38
Tumor 3 TAP 5367952 88603533 6.06
Tumor 4 TAP 4919959 53834343 9.14
Tumor 5 TAP 5150663 52828414 9.75
Tumor 6 IEPA 1534073 103888541 1.48
Tumor 7 IEPA 5354162 106898694 5.01
Tumor 8 IEPA 5483978 85612363 6.41
Tumor 9 IEPA 2520735 99570341 2.53
Tumor 10 IEPA 1408415 26232504 5.37
The total area and the necrotic portion were quantitatively measured
resulting in the percent necrosis (as shown in bold)
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ciﬁcally IEPA, to test the hypothesis that metastases inhi-
bition was due to buffering and was not speciﬁc to
bicarbonate. Metastasis is the leading cause of death from
cancer [23] and can be promoted by low pH and acidity;
which is a common feature of solid tumors. The extracel-
lular pH (pHe) of solid tumor is acidic, e.g. pHe of 6.5–7.1,
compared to normal tissues with a pHe of 7.3–7.4.
Experimental observations have shown that acid-mediated
invasion can occur via destruction of the extracellular
matrix, which is promoted by proteases and glycosidases
and may convert in situ to locally invasive cancers [29]. An
‘acid-mediated invasion hypothesis’ was developed using
mathematical models supported by empirical observations
[14], and states that: (1) tumors export H
? into the adjacent
stroma; (2) this results in damage to supporting stroma
accompanied by cell death and extracellular matrix (ECM)
break down; which (3) facilitates the invasion of the tumor
cells and consequently colonization at distant sites. As a
test of the model we observed that chronic oral adminis-
tration of sodium bicarbonate (NaHCO3), a physiologic
buffer, was able to increase tumor pHe and reduce lung
metastasis in spontaneous and experimental breast and
prostate animal models. Neutralization of tumor acidity
was measured with ﬂuorescence microscopy of a dorsal
window chamber and
31P magnetic resonance spectros-
copy. Even though NaHCO3 was effective and inexpen-
sive, its pKa may be lower than optimal, and it was unclear
whether it was working as a buffer, or if the effect was
speciﬁc for bicarbonate. Therefore, in this study we
examined a non-volatile buffer with a higher pKa value for
its effects on spontaneous metastasis.
We used IEPA with pKa * 7, and the PC3M prostate
cancer cell line was chosen because, as shown in our pre-
vious work, it was responsive to bicarbonate. IEPA was
shown to be absorbed into the blood stream, and had no
negative effects on the animal’s growth or behavior. In a
subcutaneous tumor model, we found that IEPA only
Fig. 4 a The in vivo bioluminescence of the thoracic area for each
group of mice with subcutaneous PC3M tumors. b The in vivo
bioluminescence images of the upper chest area for one representative
mouse from each group
Fig. 5 a Bioluminescence images of representative mice from the tap
versus IEPA groups at the indicated time points after venous injection
of luciferin expressing PC3M cancer cells to induce experimental
metastases. b Mean tumor bioluminescence in each group after
induction of experimental metastases, indicating fewer metastases in
the IEPA cohort than in the Tap (note log scale)
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However this decrease in size was accompanied with a
small but signiﬁcant increase in the primary tumor pH and
a substantial change in tumor anatomy; with a lower per-
centage necrosis when compared to control animals.
Although bone marrow is the most common site for
prostate cancer metastasis, it is also known to metastasize
to the lungs [24]. Spontaneous metastases, as measured by
in vivo upper thoracic bioluminescence, were decreased in
the IEPA-treated animals. Experimental metastases fol-
lowing tail vein injection were measured by total and
thoracic in vivo bioluminescence, and these were also
substantially decreased in the IEPA-treated animals.
Hence, this non-volatile buffer was effective in reducing
spontaneous and experimental metastases, compared to
bicarbonate. This suggests that the effect is due to pH
buffering and is not due to a speciﬁc bicarbonate effect per
se. The fact that both spontaneous and experimental
metastases were inhibited also suggests that the effect of
the buffer therapy is on extravasation or/and colonization
and not intravasation.
To investigate if the increase in tumor pH could be
responsible for the remarkable decrease in metastases, we
used the subcutaneous (spontaneous) model to measure the
pH of the primary tumor. We observed a slight (statistically
signiﬁcant) increase in the primary tumor pH with IEPA
treatment, accompanied by a substantial decrease in
necrotic tumor anatomy. Although statistically signiﬁcant,
the change in pHe of the primary tumor was very slight
(0.06 pH units) and the physiological relevance of this
change is unclear. In work with other tumor models, we
have observed that the effect of bicarbonate on tumor pH
was reduced in large and/or rapidly metabolizing tumors
(data not shown). The slight effects seen in this system are
also consistent with reaction-diffusion models, which also
predict that a larger and more substantial effect may take
place at the site of colonization, when tumors are small (ca.
1 mm) and poorly perfused [14]. Unfortunately, no meth-
ods are available that can measure the pHe of these small
nascent colonies. Thus, we propose that the major effect of
buffering occurs at metastatic sites, where acid load is
lower due to smaller foci and where reducing acidity can
inhibit local invasion [25–27].
Several mechanisms could potentially contribute to the
effect of buffers on tumor metastasis. Angiogenic factors,
such as vascular endothelial growth factor (VEGF-A) and
interleukin 8 (IL-8) are upregulated by acidic pHe [28].
Neovascularization inﬂuences the dissemination of cancer
cells throughout the body ultimately leading to metastasis
formation. IEPA may possibly function through increas-
ing pHe thereby affecting angiogenesis and consequently
metastasis. The acid-mediated invasion can occur via
destruction of the extracellular matrix, which is promoted
by proteases and glycosidases and may convert in situ to
locally invasive cancers [29]. Matrix metalloproteinases
(MMP-2 and MMP-9) are believed to be critical for
invasion. Even tough the MMPs have alkaline pH
optima, low pH will increase their activation and release
[11, 30]. Lysosomal proteases (cathepsins) are more
active at acid pH, are released in invasive cancers, and
function to proteolytically activate MMPs [31]. Thus, it
is possible that the buffers, by neutralizing tumor aci-
dosis, are decreasing the proteolytic enzyme activation
and prevent the ECM degradation which leads to
decrease metastasis.
In summary signiﬁcant reduction of metastasis with
IEPA buffer support the hypothesis that non-volatile buf-
fers with pKa C 7 should be more effective in buffering
extra cellular acidity [14]. This study speciﬁcally used
prostate cancer model PC3M because in our previous work
we have shown that this model was highly responsive to
bicarbonate treatment. Previous work has shown that
bicarbonate was ineffective in inhibiting metastases from
B16 melanoma. These cells are more metabolically active
and produce H
? at a higher rate, compared to PC3M (data
not shown) and hence, we hypothesize that they may be
inhibitable with more buffering power, such as that of non-
volatile buffers.
These ﬁndings suggest that non-volatile buffers, such as
imidazoles may have the potential for clinical beneﬁt.
Sodium bicarbonate is currently in two clinical trials as a
buffer; however compliance is low because of the taste.
Thus, there is a need to ﬁnd a palatable and effective
alternative. The current work shows evidence that other
buffers may be considered as an alternative to the NaHCO3
in clinical trials with the possibility of better tolerance in
addition to greater efﬁcacy. This study indicated no tox-
icity in mouse models, in agreement with previous ﬁndings
[32, 33]. Additionally, the measurements performed in the
study by Garcia Martin et al. [15] indicate that the IEPA
was able to extravasate only in the areas of the brain
affected by the glioma and not in normal brain. Thus IEPA
is not expected to cross the normal blood brain barrier
within detectable limits.
In conclusion, this study demonstrates that a non-vola-
tile buffer can reduce the incidence and growth of experi-
mental metastases in a model of prostate cancer. Previous
work using buffer therapy has exclusively used bicarbon-
ate, which may act through alternative pathways, e.g.
through activation of carbonic anhydrases. The current
work demonstrates that alternative, non-volatile buffers can
be equally efﬁcacious as bicarbonate. Thus the mechanism
of metastasis inhibition appears to be limited to pH buf-
fering. It also introduces alternative buffers that may be
more applicable in a clinical setting for acute or chronic
use.
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